BBIO - BridgeBio grants Japanese rights to Kyowa Kirin for dwarfism drug
2024-02-07 10:37:54 ET
More on BridgeBio Pharma
- BridgeBio Pharma: FDA Submission Acromidis And Top Line Results On Deck
- BridgeBio Pharma's Robust Pipeline Could Benefit From A Partner
- BridgeBio Pharma: Taking Some Profits
- BridgeBio Pharma granted FDA review for amyloidosis therapy
- BridgeBio Pharma inks royalty deal for lead drug